Srinath Palakurthi
Srinath Palakurthi
Texas A&M Health Science Center College of Pharmacy
Verified email at tamhsc.edu - Homepage
Title
Cited by
Cited by
Year
Zein in controlled drug delivery and tissue engineering
R Paliwal, S Palakurthi
Journal of Controlled Release 189, 108-122, 2014
2632014
Nanomedicine scale-up technologies: feasibilities and challenges
R Paliwal, RJ Babu, S Palakurthi
Aaps Pharmscitech 15 (6), 1527-1534, 2014
1342014
Biotinylated poly (amido) amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro
VK Yellepeddi, A Kumar, S Palakurthi
Anticancer research 29 (8), 2933-2943, 2009
1122009
Recent advances in topical ocular drug delivery
VK Yellepeddi, S Palakurthi
Journal of Ocular Pharmacology and Therapeutics 32 (2), 67-82, 2016
952016
Surface modified poly (amido) amine dendrimers as diverse nanomolecules for biomedical applications
VK Yellepeddi, A Kumar, S Palakurthi
Expert opinion on drug delivery 6 (8), 835-850, 2009
912009
Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT
VK Yellepeddi, A Kumar, DM Maher, SC Chauhan, KK Vangara, ...
Anticancer research 31 (3), 897-906, 2011
902011
Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers
DS Pisal, VK Yellepeddi, A Kumar, RS Kaushik, MB Hildreth, X Guan, ...
International journal of pharmaceutics 350 (1-2), 113-121, 2008
762008
Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer
KK Vangara, JL Liu, S Palakurthi
Anticancer research 33 (6), 2425-2434, 2013
712013
Interactions between carbon nanotubes and bioactives: a drug delivery perspective
NK Mehra, S Palakurthi
Drug Discovery Today 21 (4), 585-597, 2016
652016
Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues
A Kumar, VK Yellepeddi, GE Davies, KB Strychar, S Palakurthi
International journal of pharmaceutics 392 (1-2), 294-303, 2010
542010
Recent trends in cancer drug resistance reversal strategies using nanoparticles
S Palakurthi, VK Yellepeddi, KK Vangara
Expert opinion on drug delivery 9 (3), 287-301, 2012
532012
Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation
Y Zhao, T Seefeldt, W Chen, L Carlson, A Stoebner, S Hanson, R Foll, ...
Free Radical Biology and Medicine 47 (2), 176-183, 2009
412009
Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats
S Palakurthi, SP Vyas, PV Diwan
International journal of pharmaceutics 290 (1-2), 55-62, 2005
362005
Challenges in SN38 drug delivery: current success and future directions
S Palakurthi
Expert opinion on drug delivery 12 (12), 1911-1921, 2015
352015
SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer
KK Vangara, HI Ali, D Lu, JL Liu, S Kolluru, S Palakurthi
Aaps Pharmscitech 15 (2), 472-482, 2014
312014
Safety and toxicity of nanomaterials for ocular drug delivery applications
NK Mehra, D Cai, L Kuo, T Hein, S Palakurthi
Nanotoxicology 10 (7), 836-860, 2016
272016
Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability
B Vaidya, SK Shukla, S Kolluru, M Huen, N Mulla, N Mehra, D Kanabar, ...
Carbohydrate polymers 204, 68-77, 2019
232019
Poly (amido) amine (PAMAM) dendrimer–cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells
VK Yellepeddi, KK Vangara, S Palakurthi
Journal of nanoparticle research 15 (9), 1-15, 2013
232013
Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers
DS Pisal, VK Yellepeddi, A Kumar, S Palakurthi
Drug Delivery 15 (8), 515-522, 2008
212008
Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells
VK Yellepeddi, KK Vangara, A Kumar, S Palakurthi
Anticancer research 32 (9), 3651-3658, 2012
182012
The system can't perform the operation now. Try again later.
Articles 1–20